Approach
Team
News
Portfolio
Apply for funding
en
de
NOXXON Pharma
Developing specialized therapies to protect the immune system from chemotherapy and radiation damage.
Exit: 2018 Sale of shares via Euronext
invested since
1998
↙ Back to Portfolio
